Respiratory Disorders

In clinical settings, patients often present with various respiratory symptoms, such as congestion, coughing, and wheezing. While identifying a symptom’s underlying illness can be challenging, it is essential because even basic symptoms, such as persistent coughing, can be a sign of a more severe disorder. Advanced practice nurses must be able to differentiate between moderate and severe respiratory disorders, as well as to properly assist physicians in the diagnosis and prescription of drug treatments for patients. For this reason, it is necessary for you to have an understanding of the pathophysiology of respiratory disorders and patient factors that impact drug treatment.

To prepare:

• Review this week’s mid course review.
• Review Chapter 26 of the Huether and McCance text and Chapter 26 and Chapter 27 of the Poole Arcangelo and Peterson text.
• Select and research one of the following respiratory disorders: the common cold, pneumonia, or a chronic obstructive pulmonary disease (COPD), such as emphysema or chronic bronchitis. Consider the pathophysiology, as well as the types of drugs that would be prescribed to patients to treat this disorder.
• Select one of the following factors: genetics, gender, ethnicity, age, or behavior. Consider how your selected factor might impact the pathophysiology of the disorder and effects of prescribed drugs.
• Think about how you would facilitate the care of the patient with the patient’s care team.Remember that the care team might include physicians, advanced practice nurses, nurses, nursing assistants, home health aides, social workers, family members, etc.

Questions to be addressed in my paper:

1. A description of the respiratory disorder you selected, including its pathophysiology and types of drugs that would be prescribed to treat patients.
2. Explain how the factor you selected (Select one of the following factors: genetics, gender, ethnicity, age, or behavior.) might impact the pathophysiology of the disorder as well as the effects of prescribed drugs.
3. Explain how you would facilitate the care of the patient with the patient’s care team.
4. Summary with Conclusion

REMINDERS:

1)      2-3 pages (addressing the 4 questions above excluding the title page and reference page).

2)      Kindly follow APA format for the citation and references! References should be between the period of 2011 and 2016. Please utilize the references at least three below as much as possible and the rest from yours.

3)     Make headings for each question.

References:

Readings

• Huether, S. E., & McCance, K. L. (2012).Understanding pathophysiology (Laureate custom ed.). St. Louis, MO: Mosby.

o    Chapter 25, “Structure and Function of the Pulmonary System”

This chapter provides information relating to the structure and function of the pulmonary system to illustrate normal pulmonary function. It focuses on gas transport to build the foundation for examining alterations of pulmonary function.

o    Chapter 26, “Alterations of Pulmonary Function”

This chapter examines clinical manifestations of pulmonary alterations and disorders of the chest wall and pleura. It covers the pathophysiology, clinical manifestations, evaluation, and treatment of obstructive lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema.

o    Chapter 27, “Alterations of Pulmonary Function in Children”

This chapter focuses on alterations of pulmonary function that affect children. These alterations include disorders of the upper and lower airways.

Poole Arcangelo, V., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.

o    Chapter 18, “Otitis Media and Otitis Externa”

This chapter compares the causes and pathophysiology of two common ear infections: otitis media and otitis externa. It also identifies the types of drugs used to treat these ear infections.

o    Chapter 24, “Upper Respiratory Infections”

This chapter explores the causes, pathophysiology, and diagnostic criteria of two upper respiratory infections—the common cold and sinusitis—as well as drug therapy for both infections. It also covers monitoring patient response and patient education regarding drug therapy for these infections.

o    Chapter 25, “Asthma”

This chapter examines the causes, pathophysiology, pharmacogenomics, and diagnostic criteria of asthma. It also outlines suggested drug therapy plans for asthmatic patients.

o    Chapter 26, “Chronic Obstructive Pulmonary Disease”

This chapter explains the causes and pathophysiology of chronic obstructive pulmonary disease (COPD). It also examines the process of selecting, administering, and managing drug therapy for COPD patients.

o    Chapter 27, “Bronchitis and Pneumonia”

This chapter begins by examining the causes, pathophysiology, and diagnostic criteria of acute bronchitis, chronic bronchitis, and community-acquired pneumonia. It then explores the process of selecting, administering, and managing drug therapy for patients with bronchitis and pneumonia.

Drugs.com. (2012). Retrieved from www.drugs.com

This website presents a comprehensive review of prescription and over-the-counter drugs, including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.

National Heart Lung and Blood Institute. (2012). Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma [Online report]. Retrieved fromhttp://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm

This section of the website presents guidelines for diagnosing and managing asthma. It also outlines treatment recommendations for specific age groups.

Media

• Laureate Education, Inc. (Executive Producer). (2012h).Mid course review. Baltimore, MD: Author.

  This media is an interactive mid-course review covering course content from Weeks 1–6.

Optional Resources

• American Lung Association. (n.d.). Retrieved August 10, 2012, fromhttp://www.lung.org/
• Asthma and Allergy Foundation of America. (n.d.). Retrieved August 10, 2012, fromhttp://www.aafa.org/
• Centers for Disease Control and Prevention. (n.d.). Retrieved August 10, 2012, fromhttp://www.cdc.gov
• Cystic Fibrosis Foundation. (n.d.). Retrieved August 10, 2012, fromhttp://www.cff.org/
• Haymarket Media, Inc. (2012). Monthly prescribing reference [Online database]. Retrieved fromhttp://www.empr.com/
• Institute for Safe Medication Practices. (2012). Retrieved fromhttp://www.ismp.org/
• Medscape. (2012). Retrieved fromhttp://www.medscape.com/